Leading GMP cell CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has established low immunoreaction risk GMP ...

Likewise, iPS cells derived from type B lymphocytes demonstrate greater universal compatibility, simplifying the logistics of matching donor cells to recipients. Male donors contribute a Y chromosome, ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...

With recent advances in the development of human Inducible pluripotent stem cell derived cardiomyocytes (iPSC-CMs), novel compounds can be assessed with better disease relevance while more accurately ...

In celebration of the 10th anniversary of the United Nations' International Day of Women and Girls in Science on 11th February 2025, AMSBIO sat down with Dr Zoe Hewitt, a leading expert in cell ...

A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

(“Greenstone”) to leverage Artificial Intelligence (AI) in further developing its human induced pluripotent stem cell (iPSC) platform for diabetes treatment. This strategic collaboration ...

But it is not appropriate to test for safety in only one or a few genetic backgrounds.” Human induced pluripotent stem cells (iPSCs) can be derived directly from adult tissue and reprogrammed to ...